ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Animas As Early Warning “Sentinels” Part Of DCE Study

July 31, 1987

NCI Statisticians Disputes Bross Claim

April 27, 1979

House Subcommittee To Hold Hearings On Cancer Program

June 10, 1977

Regions Outlined In CIS Proposal

May 31, 1991

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002

Coffey Presses NCI BSA chairman David Linvingston On support For Increase In NCI Budget

April 25, 1997